Evidence map›Paper›PMID 41154345›Full record

ArticleCancers2025

Molecular Characterization of Oral Squamous Cell Carcinoma in Mexican Patients: A Genomic and Epidemiological Overview.

Javier Lopez-Gomez, Dennis Cerrato-Izaguirre, Ericka Marel Quezada-Maldonado, L A Gaitan-Cepeda, Mauricio Salcedo, Marco Antonio Hernandez-Castillo, Martín Granados-García, Yesennia Sánchez-Pérez, Claudia M García-Cuellar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Javier Lopez-GomezDirección de Investigación, Instituto Nacional de Cancerología, San Fernando No. 22, Tlalpan, Ciudad de México CP 14080, Mexico.ORCID 0000-0002-1401-3561
Dennis Cerrato-IzaguirreSubdirección de Investigación Básica, Instituto Nacional de Cancerología, San Fernando No. 22, Tlalpan, Ciudad de México CP 14080, Mexico.ORCID 0000-0002-6556-1998
Ericka Marel Quezada-MaldonadoSubdirección de Investigación Básica, Instituto Nacional de Cancerología, San Fernando No. 22, Tlalpan, Ciudad de México CP 14080, Mexico.ORCID 0000-0001-9895-8302
L A Gaitan-CepedaDepartamento de Patología Oral y Medicina Oral, División de Posgrado e Investigación, Facultad de Odontología, Universidad Nacional Autónoma de México, Ciudad de México CP 04510, Mexico.ORCID 0000-0003-4777-6829
Mauricio SalcedoUnidad de Investigación en Biomedicina y Oncología Genómica, Hospital de Gineco-Pediatría 3A, OOAD CDMX Norte, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México CP 08230, Mexico.
Marco Antonio Hernandez-CastilloDepartamento de Estomatología, Complejo Regional Sur, Benemérita Universidad Autónoma de Puebla, Puebla CP 72000, Mexico.
Martín Granados-GarcíaDepartamento de Cabeza y Cuello, Instituto Nacional de Cancerología, San Fernando No. 22, Tlalpan, Ciudad de México CP 14080, Mexico.
Yesennia Sánchez-PérezSubdirección de Investigación Básica, Instituto Nacional de Cancerología, San Fernando No. 22, Tlalpan, Ciudad de México CP 14080, Mexico.
Claudia M García-CuellarDirección de Investigación, Instituto Nacional de Cancerología, San Fernando No. 22, Tlalpan, Ciudad de México CP 14080, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) is one of the most common malignancies affecting the head and neck and account for over 90% of all oral cancers (1) [...].

Indexed as

biomarkersmutationoral squamous cell carcinomaprognosistumorigenesis

Identifiers

PMID41154345
PMCPMC12564337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.